Latest News

Includes $39.5 Million of Endorsement and Sponsorship Agreements and $6.0 Million in Headcount Costs DENVER, May 26, 2016 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition company, announced a reduction of more than $45 million in future commitments to date as part the Company's [...]
Thu, May 26, 2016
Source Latest News
Adjusted EBITDA Increases to $3.2 million, Revenue Increases to $42.9 million as Restructuring Continues DENVER, May 10, 2016 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition Company, today announced financial results for the first quarter ended March 31, 2016. Operating [...]
Tue, May 10, 2016
Source Latest News
Company Continues to Prove Commitment to Maximizing Shareholder Value DENVER, April 27, 2016 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance-lifestyle sports nutrition company, announced today that it has entered into a definitive agreement for the sale of its wholly-owned subsidiary, BioZone Laboratories, Inc. ("BioZone"). The purchase price [...]
Wed, Apr 27, 2016
Source Latest News